Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Schering/Merck Zetia 6% Market Share Is 1% Ahead Of Goal

Jan 25 2004

• By Tericke Blanchard

Related Content

Merck Raises Zocor Projections For 2005 Due To Less Than Expected Competition

Jan 25 2005

Merck/Schering's Vytorin Clears FDA

Jul 23 2004

Schering-Plough Will Eye Primary Care Acquisitions To Complement Vytorin, Zetia

Jan 05 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window